Alx Oncology Holdings (ALXO) — Financial Flexibility Index
Alx Oncology Holdings (ALXO) has a Financial Flexibility Index of -0.65x as of June 2026. Free cash flow of $-16.04 Million (operating CF $-16.06 Million minus capex $17.00K) represents -1% of total liabilities ($24.63 Million). Check ALXO tangible net assets ratio to evaluate the tangible quality of the company's equity base.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Alx Oncology Holdings Financial Flexibility Index (2018–2025)
Historical Financial Flexibility Index trend for Alx Oncology Holdings across 8 annual periods. For the full cash flow conversion analysis, see ALXO operating cash flow.
Annual Financial Flexibility Index for Alx Oncology Holdings (2018–2025)
Year-by-year free cash flow to debt coverage for Alx Oncology Holdings . Explore ALXO debt coverage from operations to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -2.54x | $-83.93 Million | $-84.14 Million | $33.06 Million | ▲ +28.6% |
| 2024 | -3.56x | $-121.47 Million | $-121.91 Million | $34.16 Million | ▼ -45.6% |
| 2023 | -2.44x | $-129.09 Million | $-130.36 Million | $52.84 Million | ▼ -19.7% |
| 2022 | -2.04x | $-87.80 Million | $-89.22 Million | $43.02 Million | ▲ +44.7% |
| 2021 | -3.69x | $-63.18 Million | $-68.10 Million | $17.13 Million | ▲ +40.2% |
| 2020 | -6.16x | $-38.26 Million | $-38.29 Million | $6.21 Million | ▼ -385.6% |
| 2019 | -1.27x | $-13.90 Million | $-14.25 Million | $10.95 Million | ▲ +79.7% |
| 2018 | -6.24x | $-12.54 Million | $-13.19 Million | $2.01 Million | — |